Healthcare Technologies award winner 2013
The metra™ system fundamentally transforms the decades-old liver retrieval and transplant procedure. The innovative product keeps a human liver alive outside of the body for up to 24 hours. It autonomously manages the organ without the intervention of a clinician and should increase the number and quality of available livers.
Team Consulting Ltd and OrganOx Ltd
The judging panel commented:
“The judges described this innovation as 'a unique, world –leading technology' which was 'extremely innovative' and had 'great potential, for significant impact'.
"This technology has the capacity to impact on so many lives through making liver transplants even more possible than before."
Nanotechnology Revolutionises Sentinel Lymph Node Procedure in Fight Against Breast Cancer
Endomagnetics’ nanotechnology extends availability of sentinel lymph node localisation procedure by removing the need for radioisotopes in tracking breast cancer.
Fluidic Technology Offers New Hope to Amputees
Orthomobility Ltd, NHS National Innovation Centre and Revalidatiecentrum De Hoogstraat
A unique patented fluidic controlled prosthetic knee joint for amputees provides top class function in fast walking, stumble recovery, leg-over-leg downstairs and down slope walking. These achievements rank in the world's highest performances, and are based on the micro properties of dynamic fluids, delivering weight bearing power.
Chair 4 Life. The Chair for Living
Renfrew Group International, NHS NIC. Devices 4 Dignity
Chair4Life, a highly modular, powered pediatric wheelchair addresses physical and social demands of 80% of users aged 4 - 18.
Readily updated and modified through a catalogue of attachments and components. Customised posture control and support as the child grows. Allows user to keep C4L 3x longer than at present.
Zilico Limited, Triteq Limited, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust
Zilico has worked with Triteq to develop a next generation cancer diagnostic platform that removes subjectivity and increases accuracy of results, allowing for improvement and extension of screening programmes.
The lead product, ZedScan, within cervical cancer can differentiate cervical dysplasia, providing a real-time diagnosis that avoids biopsies and waiting times.